Patent application number | Description | Published |
20140182013 | KEY GENE REGULATING CELL WALL BIOSYNTHESIS AND RECALCITRANCE IN POPULUS, GENE Y - This disclosure provides methods and transgenic plants for improved production of renewable biofuels and other plant-derived biomaterials by altering the expression and/or activity of Gene Y, an O-acetyltransferase. | 06-26-2014 |
20150353948 | Transcription Factor Which Regulates Flavonoid, Phenylpropanoid, Tyrosine, and Tryptophan Pathways - The invention provides plants having desirable levels of sugar release and/or lignin synthesis. The invention further provides methods of selecting plants with such desirable levels of sugar release and/or lignin synthesis; methods of genetically modifying plants to modulate lignin synthesis, sugar release, and modulating phenylalanine, tyrosine, tryptophan and flavonoid production; and uses of such plants. | 12-10-2015 |
20160053275 | KEY GENE REGULATING PLANT CELL WALL RECALCITRANCE - This disclosure provides plants having desirable levels of lignin synthesis, sugar release, S/G ratio, and resistance to stress and pathogens; methods of selecting plants with such desirable levels of lignin synthesis, sugar release, S/G ratio, and resistance to stress and pathogens; methods of genetically modifying plants to modulate lignin synthesis, sugar release, S/G ratio, and resistance to stress and pathogens; and uses of such plants. The inventors have determined that the expression and/or activity of POPTR_0014s08530, a gene encoding an | 02-25-2016 |
Patent application number | Description | Published |
20090326020 | COMPOUNDS FOR TREATMENT OF CANCER - Compounds according to formula (I) are disclosed | 12-31-2009 |
20110118228 | Enzymatic production or chemical synthesis and uses for 5,7-dienes and UVB conversion products thereof - Provided herein are steroidal compounds that are androsta-5,7-dienes or a pregna-5,7-dienes and ultraviolet B (UVB) conversion products thereof which includes pharmaceutical compositions of the steroidal compounds as shown in Tables 1 and 2. Also provided is a method for producing hydroxylated metabolites of cholecalciferol or ergocalciferol via the P450scc (CYP11A1) or CYP27B1 enzyme systems where the hydroxylase has an activity to hydroxylate position C20 of a secosteroid or its 5,7-dieneal precursor and the hydroxylated metabolites so produced. In addition, a method for inhibiting proliferation of either a normally or abnormally proliferating cell by contacting the cell with any of the compounds described herein. A related method is provided of treating a condition associated with the proliferating cell such as a cancer, a skin disorder, a defect in cell differentiation, cosmetic, prophylaxsis, or healthy cell maintenance. | 05-19-2011 |
20110257196 | COMPOUNDS FOR TREATMENT OF CANCER - The present invention relates to novel compounds having anti-cancer activity, methods of making these compounds, and their use for treating cancer and drug-resistant tumors, e.g. melanoma, metastatic melanoma, drug resistant melanoma, prostate cancer and drug resistant prostate cancer. | 10-20-2011 |
20120071524 | COMPOUNDS FOR TREATMENT OF CANCER - The present invention relates to novel compounds having anti-cancer activity, methods of making these compounds, and their use for treating cancer and drug-resistant tumors, e.g. melanoma, metastatic melanoma, drug resistant melanoma, prostate cancer and drug resistant prostate cancer. | 03-22-2012 |
20120258938 | Enzymatic Production or Chemical Synthesis and Uses for 5,7-Dienes and UVB Conversion Products Thereof - Provided herein are steroidal compounds that are androsta-5,7-dienes or pregna-5,7-dienes and ultraviolet B (UVB) conversion products thereof and cholecalciferol derivatives hydroxylated at one or more of C1, C17, C20, C23, C24, C25, and C26 which includes pharmaceutical, cosmeceutical or nutraceutical compositions of the steroidal compounds as shown in Tables 1A, 2A and 3. Also provided is a method for producing hydroxylated metabolites of cholecalciferol via CYP11A1, CYP24, CYP27A1, or CYP27B1 enzyme systems where the hydroxylase has an activity to hydroxylate position C1 or C20 or other position of the sidechain of a secosteroid or its 5,7-dieneal precursor and the hydroxylated metabolites so produced. Methods are provided for inhibiting proliferation of either a normally or abnormally proliferating cell, for modifying immune activity, or for treating a condition associated with the proliferating or quiescent cell or immune cells by contacting the cell with or administering any of the compounds described herein. | 10-11-2012 |
20140200201 | Enzymatic Production or Chemical Synthesis and Uses for 5,7-Dienes and UVB Conversion Products Thereof - Provided herein are steroidal compounds that are androsta-5,7-dienes or a pregna-5,7-dienes and ultraviolet B (UVB) conversion products thereof which includes pharmaceutical compositions of the steroidal compounds as shown in Tables 1 and 2. Also provided is a method for producing hydroxylated metabolites of cholecalciferol or ergocalciferol via the P450scc (CYP11A1) or CYP27B1 enzyme systems where the hydroxylase has an activity to hydroxylate position C20 of a secosteroid or its 5,7-dieneal precursor and the hydroxylated metabolites so produced. In addition, a method for inhibiting proliferation of either a normally or abnormally proliferating cell by contacting the cell with any of the compounds described herein. A related method is provided of treating a condition associated with the proliferating cell such as a cancer, a skin disorder, a defect in cell differentiation, cosmetic, prophylaxsis, or healthy cell maintenance. | 07-17-2014 |
20140213623 | COMPOUNDS FOR TREATMENT OF CANCER - The present invention relates to a compound of formula XXII and a compound of formula 17ya, which are defined as anywhere in the specification, to a composition comprising the same, and to a method of using thereof in the treatment of various forms of cancer. | 07-31-2014 |
Patent application number | Description | Published |
20090072131 | Estimation of Crystal Efficiency With Axially Compressed Sinogram - The present invention provides a method for estimating crystal efficiency in a PET detector that takes axial compression into account. It does so via an iterative methodology in which a μ-map is first generated and then is used to obtain a solution for the equation | 03-19-2009 |
20090072152 | Apparatus For Automatic Calibration of PET/CT Systems - A calibration system for a combined Positron Emission Tomography (PET)/Computed Tomography scanner system, may have a support structure carrying a rotation motor driving a phantom, wherein the phantom has at least two phantom rods and the rods are positioned such that they are neither parallel nor connected to each other. | 03-19-2009 |
20090074152 | Methods of Performing PET Sinogram Quality Check - A method for determining quality of sinograms produced by a medical imaging device. The method may include placing a uniform phantom object in the field of view of the medical imaging device; acquiring one or more phantom sinograms of the uniform phantom object; establish a set of parameters for the acquired one or more phantom sinograms; and determine, based on pre-set ranges of the parameters, the quality of sinograms produced by the medical imaging device. The parameters may be one or more parameters of a group of parameters consisting of block uniformity, block efficiency, randoms rate, scanner efficiency, and scatter ratio. | 03-19-2009 |
20100080339 | MODELING OF THE POINT-SPREAD-FUNCTION IN SINGLE-PINHOLE AND MULTI-PINHOLE SPECT RECONSTRUCTION - A system and method for reconstructing single photon emission computed tomography data acquired with a pinhole collimator includes sub-dividing each voxel in the imaging target object space into sub-voxels and sub-dividing each of the detector bins in the gamma camera detector into sub-bins, connecting the centers of each of the sub-voxels to each of the detector sub-bins through a pinhole provided in the pinhole collimator by ray tracing and for each ray connecting the centers of each of the sub-voxels to each of the detector sub-bins, the transmission probability is calculated by analytically solving the intersections between the ray and the pinhole surfaces. Then, a geometric-response-function of the pinhole collimator is computed which is then convolved with the intrinsic-response-function of the detector to obtain the PSF. | 04-01-2010 |
20110127413 | Systems and Methods for Calibrating Time Alignment For A Positron Emission Tomography (PET) System - A representative positron emission tomography (PET) calibration system includes a PET scanner having a ring detector, a phantom that is placed at approximately the center of the ring detector, and a time alignment calibration manager that is coupled to the PET scanner. The time alignment calibration manager detects coincidence events from the phantom, calculates position of time of flight events from the ring detector based on the detected coincidence events, and calculates time offsets for the ring detector using a mean value calculation based on the calculated position of the time of flight events. | 06-02-2011 |
Patent application number | Description | Published |
20120139345 | CONTROL METHOD OF HYBRID POWER BATTERY CHARGER - A power supply system and method for operating same. The power supply system is connectable to receive power from an adapter and supply power to a load. The power supply system includes a rechargeable battery, a buck mode circuit, and a boost mode circuit. A switching circuit switches between the buck mode circuit and boost mode circuit for supplying power to the load. If the power required by the load reaches a first predetermined level related to an adapter overload condition for a first predetermined time, the switching circuit disconnects said buck mode circuit from the load and connects the rechargeable battery and the boost mode circuit to said load. The first predetermined level may be established by a first predetermined percent of the current of a dynamic power management level established by the load, which is related to a power level below that which can be provided by the adapter. | 06-07-2012 |
20120139500 | METHOD FOR LIMITING BATTERY DISCHARGING CURRENT IN BATTERY CHARGER AND DISCHARGER CIRCUIT - A power supply system includes a rechargeable battery to deliver a supply current to a load and a circuit to limit a discharge current when the rechargeable battery is supplying power to the load. The power supply system may further include an integrator for integrating a discharge voltage representing the discharge current that exceeds a predetermined limit, a pulse-width-modulation (PWM) circuit for producing a control signal having a PWM duty cycle representing the discharge voltage, and a driver circuit for delivering the supply current to said load according to said control signal. In one embodiment, a digital register is used to set the battery discharging current limit, in another embodiment an analog circuit is used to set the battery discharging current limit, and in yet another embodiment or a combination of the digital register and analog circuit is used to set the battery discharging current limit. | 06-07-2012 |
20160072331 | METHOD FOR LIMITING BATTERY DISCHARGING CURRENT IN BATTERY CHARGER AND DISCHARGER CIRCUIT - A power supply system includes a rechargeable battery to deliver a supply current to a load and a circuit to limit a discharge current when the rechargeable battery is supplying power to the load. The power supply system may further include an integrator for integrating a discharge voltage representing the discharge current that exceeds a predetermined limit, a pulse-width-modulation (PWM) circuit for producing a control signal having a PWM duty cycle representing the discharge voltage, and a driver circuit for delivering the supply current to said load according to said control signal. In one embodiment, a digital register is used to set the battery discharging current limit, in another embodiment an analog circuit is used to set the battery discharging current limit, and in yet another embodiment or a combination of the digital register and analog circuit is used to set the battery discharging current limit. | 03-10-2016 |
Patent application number | Description | Published |
20090079937 | Adaptive Photoscreening System - Briefly described, one embodiment of the system, among others, can be implemented as follows. The system includes a computer control system and an environmental light source that is controlled by the computer control system such that an amount of light provided by the environmental light source is adjusted by the computer control so that ocular parameters of an examinee are within a targeted range. Further, the system includes an irradiation system that provides multiple angle and axial eccentricity illuminations and selective wavelength irradiation based upon instructions received from the computer control system, wherein the computer control system instructs the irradiation system to provide different irradiation characteristics for different screening procedures. Also, the system includes an image detection system that captures ocular images of the examinee, wherein the computer control system analyzes captured images and provides results of in-situ analysis. Other systems and methods are also provided. | 03-26-2009 |
20110157550 | Adaptive Photoscreening System - Briefly described, one embodiment of the system, among others, can be implemented as follows. The system includes a computer control system and an environmental light source that is controlled by the computer control system such that an amount of light provided by the environmental light source is adjusted by the computer control so that ocular parameters of an examinee are within a targeted range. Further, the system includes an irradiation system that provides multiple angle and axial eccentricity illuminations and selective wavelength irradiation based upon instructions received from the computer control system, wherein the computer control system instructs the irradiation system to provide different irradiation characteristics for different screening procedures. Also, the system includes an image detection system that captures ocular images of the examinee, wherein the computer control system analyzes captured images and provides results of in-situ analysis. The system can further include a device, for example a lens or lens system, positioned in the system to be between the eye of the examinee and the image detection system during photoscreening for shifting the neutralization of the system to a desired region for a specific population of examinees. Other systems and methods are also provided. | 06-30-2011 |